News
Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil
News
Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum
News
Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta
News
After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct
News
Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds
Use of heroin-blocking agents on addicted ex-convicts "will cure their desire for heroin within three months," a Harvard Medical School professor said yesterday.
Vernon Patch, associate professor of Psychiatry and head of the drug rehabilitation center at Boston City Hospital, said he plans to test the drug naltrexone hydrochloride on paroled addicts from Deer Island Prison. "It will help them protect themselves against heroin," he said.
"Inmates leave prison with drug hunger and seek drugs upon release, so they just return to their old lives. The blocking agents prevent them from getting a high on heroin," Patch said.
Patch added that the drug is being tested at McClain Hospital and the Washingtonian Center, both in Boston, but under different control conditions. Patch would be the first to use the drug on former inmates.
Experimentation
William J. Curran, professor of Legal Medicine at the Medical School, said. "I am not categorically against the use of inmates in experimentation, in or out of prison." Curran is a member of the Committee of Psychiatry at the Medical School, one of two groups which gives Harvard's sanction to this type of experimentation.
Want to keep up with breaking news? Subscribe to our email newsletter.